Loss- and gain-of-function assays showed that, in addition to the effects of LOXL2 on tumor cell invasion and tumor metastasis [16,[33], [34], [35]], both L2Δ13 and LOXL2 promote esophageal cancer cell proliferation and tumor growth in xenograft experiments. This evidence concerns the gene LOXL2 and esophageal cancer.